BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1142 related articles for article (PubMed ID: 7691640)

  • 1. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood.
    Zauli G; Vitale L; Brunelli MA; Bagnara GP
    Exp Hematol; 1992 Aug; 20(7):850-4. PubMed ID: 1378407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of early hematopoietic precursors in human cord blood.
    Abboud M; Xu F; LaVia M; Laver J
    Exp Hematol; 1992 Oct; 20(9):1043-7. PubMed ID: 1281782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cyclophosphamide followed by GM-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells.
    Patrone F; Ballestrero A; Balleari E; Bogliolo F; Brema F; Ferrando F; Ghio R; Timitilli S
    Haematologica; 1992; 77(6):457-62. PubMed ID: 1289182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
    Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
    Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of cord blood progenitors and use for hemopoietic reconstitution.
    Gabutti V; Timeus F; Ramenghi U; Crescenzio N; Marranca D; Miniero R; Cornaglia G; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():105-12. PubMed ID: 7691315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential thrombocythemia: impaired regulation of megakaryocyte progenitors.
    Zauli G; Catani L; Gugliotta L; Gaggioli L; Vitale L; Belmonte MM; Aglietta M; Bagnara GP
    Int J Cell Cloning; 1991 Jan; 9(1):43-56. PubMed ID: 2010654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
    Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.